Rubius Therapeutics Ownership | Who Owns Rubius Therapeutics?

Rubius Therapeutics Ownership Summary

Rubius Therapeutics is owned by 3.27% institutional investors, and 96.73% retail investors. Fidelity® VIP Growth Initial is the top mutual fund, with 0.15% of its assets in Rubius Therapeutics shares.

RUBY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rubius Therapeutics	3.27%	-	96.73%
Sector	Healthcare Stocks	47.25%	8.01%	44.75%
Industry	Biotech Stocks	45.35%	7.81%	46.83%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity® VIP Growth Initial	134.86K	0.15%	-
Fidelity Advisor® Equity Growth I	80.60K	0.09%	-
Fidelity® Growth Discovery	54.08K	0.06%	-
Fidelity Advisor® Series Equity Gr	28.49K	0.03%	-
Pacific Select Large-Cap Growth I	12.60K	0.01%	12.60K
GF NASDAQ Bio-Tech Idx QDII RMB A	5.49K	0.01%	3.89K
Blackrock Russell 2000 Alpha Tilts Fd A	1.50K	0.00%	66.00
Guggenheim Active Allocation Fund	547.00	0.00%	-
BMO MSCI Genomic Innovation ETF	428.00	0.00%	-
BlackRock LifePath Dynamic 2040 F	26.00	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 24, 2023	Appelhans Dannielle	CEO and President	Sell	$1.32K
Feb 01, 2023	CAGNONI PABLO J	-	Sell	$2.11K
Feb 01, 2023	Appelhans Dannielle	CEO and President	Sell	$969.50
Jan 31, 2023	CAGNONI PABLO J	-	Sell	$1.74K
Jan 31, 2023	Turka Laurence A.	Chief Scientific Officer	Sell	$622.32

Insider Transactions Trends

Date	Buy	Sell
2023 Q1	-	5
2022 Q3	-	1
2022 Q2	1	-
2022 Q1	-	3
2021 Q4	-	-

RUBY Ownership FAQ

Who Owns Rubius Therapeutics?

Rubius Therapeutics shareholders are primarily institutional investors at 3.27%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Rubius Therapeutics's industry, Biotech Stocks , is 45.35%, which Rubius Therapeutics falls below.

Does Blackrock own Rubius Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rubius Therapeutics.

Who is the top mutual fund holder of Rubius Therapeutics shares?

Fidelity® VIP Growth Initial is the top mutual fund holder of Rubius Therapeutics shares, with 0.15% of its total shares outstanding invested in 134.86K Rubius Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools